Comparison of the Effects on Airway Conductance of a New Selective Beta-adrenergic Blocking Drug, Atenolol, and Propranolol in Asthmatic Subjects
Overview
Authors
Affiliations
Five patients with mild to moderate asthma were studied after an intravenous saline control followed by atenolol (i.v. 7-9mg) and propranolol (i.v. 0.2-1.0 mg) in a body plethysmograph. Following propranolol, heart rate did not change but specific airway conductance dropped with 65% and airway resistance increased with 130%. Following atenolol, there was a dose-related decrease in heart rate (25% after 9 mg i.v.) and a slight but not significant tendency to a decrease in airway conductance on the highest doses. None of the patients experienced any change in symptoms after administration of atenolol but after propranolol two patients had worsened symptoms. It is concluded that, in contrast to propranolol, atenolol blocks the beta-receptors in the heart preferentially to those in the lungs, and thus could be given to patients with obstructive lung disease.
Cardioselective beta-blocker use in patients with reversible airway disease.
Salpeter S, Ormiston T, Salpeter E Cochrane Database Syst Rev. 2001; (2):CD002992.
PMID: 11406056 PMC: 8689715. DOI: 10.1002/14651858.CD002992.
Lawrence D, Sahay J, Chatterjee S, Cruickshank J Eur J Clin Pharmacol. 1982; 22(6):501-9.
PMID: 6127219 DOI: 10.1007/BF00609622.
Lofdahl C, Dahlof C, Westergren G, Olofsson B, SVEDMYR N Eur J Clin Pharmacol. 1988; 33 Suppl:S25-32.
PMID: 2836204 DOI: 10.1007/BF00578409.
Lipworth B, BROWN R, McDevitt D Br J Clin Pharmacol. 1989; 28(1):95-102.
PMID: 2570601 PMC: 1379975. DOI: 10.1111/j.1365-2125.1989.tb03510.x.
Mattson K, Poppius H Eur J Clin Pharmacol. 1978; 14(2):87-92.
PMID: 720379 DOI: 10.1007/BF00607436.